Drug Pipeline

TAS-102 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or…		 overall status: "Recruiting" → "Active Not Recruiting"
2026-05-28 NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or…		 Trial sites reduced: 186 -> 158 locations
2026-05-28 NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or…		 date change Primary completion pushed: 2026-05-14 -> 2026-06-15
2026-05-28 NCT06346392
AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or…		 date change Completion pushed: 2026-09-14 -> 2026-10-14
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… Gastric Cancer Active, Not Recruiting
Phase 2
NCT05343013 TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal… Colorectal Cancer Recruiting
Phase 1
NCT04920032 Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon… Colon Adenocarcinoma Recruiting
Sponsors Running TAS-102 Trials
University of California, Irvine (1) M.D. Anderson Cancer Center (1) AstraZeneca (1)
Disease Areas
Colorectal Cancer (2) Gastric Cancer (1)
Get alerts when TAS-102 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free